» Articles » PMID: 33346226

Methylation Assessment of Two and Genes in Oral Squamous Cell Carcinoma Patients

Overview
Date 2020 Dec 21
PMID 33346226
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oral squamous cell carcinoma (OSCC) is one of the most important types of oral malignancies. gene family members as well as have critical roles in regulation of Wnt signaling as one of the main determining pathway in oral carcinogenesis. This study aimed to identify promoter methylation status of genes to provide possible biomarkers for early detection and treatment of OSCC patients.

Methods: A case control study was performed on 31 fresh tissues obtained from oral cavity of patients affected by OSCC and 31 fresh corresponding tissues from normal healthy controls in Tehran and, between the years of 2016-2018. Purified DNA from tissue samples was subjected to bisulfite treatment and then methylation specific polymerase chain reaction (MSP-PCR) was carried out on treated DNA samples.

Results: promoter was methylated in none of OSCC samples while it was methylated in 16.1% of healthy controls. 16.1% of OSCC samples were detected to be semimethylated and 22.6% of healthy normal samples were methylated for promoter gene. Meaningful difference was found in promoter methylation among OSCC patients and healthy controls. Significant correlation was found between promoter methylation and tumor grade. The age of all enrolled samples was demonstrated to have strong effect on promoter methylation of studied genes.

Conclusion: Hypomethylation of and genes in higher grades of OSCC samples may indicate the pivotal role of their expression in tumor cells invasion and progression through modulation of Wnt signaling pathway. Further study required to determine simultaneous expression of those genes and Wnt signaling elements at mRNA and protein levels.

Citing Articles

DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway.

Guo W, Qu Y, Yu Y, Li X, Liang Z, Wang Z Aging (Albany NY). 2024; 16(10):9204-9215.

PMID: 38795388 PMC: 11164507. DOI: 10.18632/aging.205864.


Construction of Prognostic Risk Prediction Model of Oral Squamous Cell Carcinoma Based on Nine Survival-Associated Metabolic Genes.

Huang Z, Yao Y, Chen T, Zhao Y, Zhang C, Niu Y Front Physiol. 2021; 12:609770.

PMID: 33815132 PMC: 8011568. DOI: 10.3389/fphys.2021.609770.

References
1.
Lee A, He B, You L, Xu Z, Mazieres J, Reguart N . Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma. Biochem Biophys Res Commun. 2004; 323(4):1246-50. DOI: 10.1016/j.bbrc.2004.09.001. View

2.
Wang C, Yue Y, Shao B, Qiu Z, Mu J, Tang J . Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling. Cell Physiol Biochem. 2017; 41(5):1709-1724. DOI: 10.1159/000471861. View

3.
Goessling W, North T, Loewer S, Lord A, Lee S, Stoick-Cooper C . Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell. 2009; 136(6):1136-47. PMC: 2692708. DOI: 10.1016/j.cell.2009.01.015. View

4.
Fatima S, Lee N, Tsang F, Kolligs F, Ng I, Poon R . Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma. Oncogene. 2012; 31(38):4233-44. DOI: 10.1038/onc.2011.580. View

5.
Pendas-Franco N, Aguilera O, Pereira F, Gonzalez-Sancho J, Munoz A . Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res. 2008; 28(5A):2613-23. View